Skip to content
drillr.ai
Sign up

ANVS

Annovis Bio, Inc.

NYSE · Healthcare · Biotechnology · US

$1.39
+0.72%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue—————
Gross Profit—————
Operating Expenses
R&D Expense28.7B25.2M20.0M38.8M16.5M
SG&A Expense3.7B4.5M6.7M6.2M9.0M
General & Admin Expense3.7B4.5M6.7M6.2M9.0M
Selling & Marketing Expense—————
Other Expenses(32.4B)————
Total Operating Expenses49.5M29.7M26.7M45.0M25.5M
Cost and Expenses49.5M29.7M26.7M45.0M25.5M
Operating Income (EBIT)(49.5M)(29.7M)(26.7M)(45.0M)(25.5M)
Non-Operating
Interest Income618.1K699.1K331.8K667.9K182.7K
Interest Expense1.6M—1.9M——
Net Interest Income(971.2K)699.1K(1.5M)667.9K182.7K
Other Non-Op Income/Expense6.8K841.1K2.1M(11.2M)182.7K
Non-Operating Income (excl Interest)(449.9K)(841.1K)(4.0M)11.2M(182.7K)
EBT (Pre-Tax Income)(49.5M)(28.9M)(24.6M)(56.2M)(25.3M)
Income Tax Expense—————
Bottom Line
Net Income(49.5M)(28.9M)(24.6M)(56.2M)(25.3M)
Earnings from Cont. Ops(49.5M)(28.9M)(24.6M)(56.2M)(25.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(49.5M)(28.9M)(28.2M)(56.2M)(25.3M)
Per Share
Basic EPS($1.79)($1.40)($2.02)($6.23)($3.10)
Diluted EPS($1.79)($1.40)($2.31)($6.23)($3.10)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding37.5M20.6M12.2M9.0M8.2M
Diluted Shares Outstanding37.5M20.6M12.2M9.0M8.2M
Profitability Metrics
EBITDA(49.1M)(28.9M)(22.7M)(56.2M)(25.3M)
D&A—————
EBIT(49.1M)(28.9M)(22.7M)(56.2M)(25.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026